Cl-amidine also prevents apoptosis of lung epithelial cells due to NET release, suggesting that PAD4 inhibitors could be used to prevent immunothrombosis and lung injury in COVID-19 (13, 138). The gene discussed is PADI4; the disease is COVID-19.